期刊文献+

细胞外信号调节激酶与胶原在肝纤维化过程中的表达及相关性 被引量:2

Expression of extracellular signal-regulated kinase in hepatic fibrosis and its correlation with collagen type Ⅰ and Ⅲ
下载PDF
导出
摘要 目的:观察细胞外信号调节激酶(ERK)在肝纤维化组织中的表达变化及其与Ⅰ、Ⅲ型胶原表达的相关性,并探讨其在肝纤维化发生中的作用.方法:二甲基亚硝胺(DMN)诱导大鼠肝纤维化,于用药1、2、3wk分别取肝组织;收集临床肝手术标本,包括纤维化肝组织和远癌的纤维化肝组织,以正常肝组织做对照.采用免疫组化法检测ERK在肝纤维化组织中表达和定位及其与Ⅰ、Ⅲ型胶原表达的相关性.结果:随着大鼠注射DMN时间的延长,ERK、Ⅰ、Ⅲ型胶原的表达逐渐增加,且在各时间组肝组织中ERK的表达与Ⅰ、Ⅲ型胶原的表达呈正相关(1wk:r=0.75,0.68,P<0.05;2wk:r=0.82,0.78,P<0.05;3wk:r=0.74,0.83,P<0.05).同样,ERK在人肝纤维化组较对照组表达增加(1.068±0.258vs0.035±0.011,P<0.05),且ERK的表达与Ⅰ、Ⅲ型胶原的表达正相关(r=0.87,0.88,均P<0.05).结论:ERK可能与肝纤维化的发生机制及胶原合成密切相关. AIM: To investigate the expression of ERK during the development of hepatic fibrosis and the correlation of ERK and I, Ⅲ collagens. METHODS: Hepatic fibrosis was induced by subcutaneous injection of DMN. Rats were killed for study at the end of first, second, third weeks and the clinical operative liver samples were col-lected. The development expression and location of the ERK in the hepatic tissue and the correlation of ERK with collagen I, Ⅲ were assessed by means of immunohistochemistry. RESULTS: The expression of ERK was increased and was closely correlated with that of collagen I and Ⅲ during the development of rat fibrosis at every time point (1wk: r=0.75, 0.68, P 〈 0.05; 2 wk: r = 0.82, 0.78, P〈0.05; 3 wk: r=0.74, 0.83, P 〈 0.05). Similarly, the expression of ERK was enhanced in human fibrotic tissues (1.068 ± 0.258 vs 0.035 ±0.011, P 〈 0.05), which was correlated with that of collagen I and Ⅲ (r=0.87, 0.88, all P 〈 0.05). CONCLUSION: The ERK signal pathway may play an important role in the pathogenesis of he- patic fibrosis.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第8期770-774,共5页 World Chinese Journal of Digestology
关键词 细胞外信号调节激酶 肝纤维化 细胞外基质 Extracellular signal-regulated kinase Hepatic fibrosis Extracellular matrix
  • 相关文献

参考文献21

  • 1Li C, Scott DA, Hatch E, Tian X, Mansour SL. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 2007; 134:167-176.
  • 2Yuantai W, Tiancai W, Qiu Z. PD98059 inhibits expression of pERK1 protein and collagen alphal(I) mRNA in rat pancreatic stellate cells activated by platelet-derived growth factor. Indian J Gastroenterol 2005; 24:100-103.
  • 3Guo J, Friedman SL. Hepatic fibrogenesis. Semin Liver Dis 2007; 27:413-426.
  • 4Parsons CJ, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepato12007; 22 Suppl 1:S79-S84.
  • 5Hirosawa M, Nakahara M, Otosaka R, Imoto A, Okazaki T, Takahashi S. The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells. Leuk Res 2008 Nov 6. [Epub ahead of print].
  • 6Brown MD, Sacks DB. Protein scaffolds in MAP kinase signalling. Cell Signal 2009; 21:462-469.
  • 7Chopra P, Kanoje V, Semwal A, Ray A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin Investig Drugs 2008; 17: 1411-1425.
  • 8Schwer CI, Guerrero AM, Humar M, Roesslein M, Goebel U, Stoll P, Geiger KK, Pannen BH, Hoetzel A, Schmidt R. Heine oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the extracellular signal-regulated kinasel/2 pathway. J Pharmacol Exp Ther 2008; 327: 863-871.
  • 9Qiang H, Lin Y, Zhang X, Zeng X, Shi J, Chen YX, Yang MF, Han ZG, Xie WF. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int 2006; 26:1126-1137.
  • 10Shatos MA, Gu J, Hodges RR, Lashkari K, Dartt DA. ERK/p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet ceils in culture. Invest Ophthalmol Vis Sci 2008; 49:3351-3359.

同被引文献32

  • 1李淑娟,董晓华,武海霞,张力,张丹参.大黄及其有效成分药理作用研究进展[J].医学综述,2005,11(1):76-78. 被引量:97
  • 2王欣欣,郎振为,孟忻,孙琳,王泰龄,赵景民,张世杰.α-SMA在慢性乙型病毒性肝炎肝组织中的表达[J].临床肝胆病杂志,2005,21(2):76-78. 被引量:9
  • 3李伟平,任浩洋,张宝阳,虞朝辉,厉有名.VEGF在大鼠慢性酒精性肝损伤中的表达[J].世界华人消化杂志,2006,14(18):1766-1770. 被引量:9
  • 4Szeto CC,Lai KB,Chow KM,Szeto CY,Wong TY,Li PK.Differential effects of transforming growthfactor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell.Nephron Exp Nephrol 2005;99:e95-e104.
  • 5Okazaki I,Watanabe T,Hozawa S,Niioka M,Arai M,Maruyama K.Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery.Keio Jmed 2001;50:58-65.
  • 6Friedman SL.Seminars in medicine of the Beth Israel Hospital,Boston.The cellular basis of hepaticfibrosis.Mechanisms and treatment strategies.N Engl J Med 1993;328:1828-1835.
  • 7Olaso E,Friedman SL.Molecular regulation of hepatic fibrogenesis.J Hepatol 1998;29:836-847.
  • 8Friedman SL,Maher JJ,Bissell DM.Mechanisms and therapy of hepatic fibrosis:report of the AASLD Single Topic Basic Research Conference.Hepatology 2000;32:1403-1408.
  • 9Friedman SL.Molecular regulation of hepatic fibrosis,an integrated cellular response to tissue injury.J Biol Chem 2000;275:2247-2250.
  • 10Gressner OA,Weiskirchen R,Gressner AM.Biomarkers of hepatic fibrosis,fibrogenesis and genetic pre-disposition pending between fictionand reality.J Cell Mol Med 2007;11:1031-1051.

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部